| Literature DB >> 34884365 |
Naoki Segi1, Hiroaki Nakashima1,2, Tokumi Kanemura2, Kotaro Satake2, Kenyu Ito2, Mikito Tsushima2, Satoshi Tanaka2, Kei Ando1, Masaaki Machino1, Sadayuki Ito1, Hidetoshi Yamaguchi1,2, Hiroyuki Koshimizu1,2, Hiroyuki Tomita1, Jun Ouchida1,2, Yoshinori Morita1, Shiro Imagama1.
Abstract
The aim of the current study was to compare outcomes between lateral access vertebral reconstruction (LAVR) using a rectangular footplate cage and the conventional procedure using a cylindrical footplate cage in patients with osteoporotic vertebral fracture (OVF). We included 46 patients who underwent anterior-posterior combined surgery for OVF: 24 patients underwent LAVR (Group L) and 22 underwent the conventional procedure (Group C). Preoperative, postoperative, and 1- and 2-year follow-up X-ray images were used to measure local lordotic angle, correction loss, and cage subsidence (>2 mm in vertebral endplate depression). In anterior surgery, the operation time was significantly shorter (183 vs. 248 min, p < 0.001) and the blood loss was significantly less (148 vs. 406 mL, p = 0.01) in Group L than in Group C. In Group C, two patients had anterior instrumentation failure. Correction loss was significantly smaller in Group L than in Group C (1.9° vs. 4.9° at 1 year, p = 0.02; 2.5° vs. 6.5° at 2 years, p = 0.04, respectively). Cage subsidence was significantly less in Group L than in Group C (29% vs. 80%, p < 0.001). LAVR using a rectangular footplate cage is an effective treatment for OVF to minimize surgical invasiveness and postoperative correction loss.Entities:
Keywords: anterior and posterior combined surgery; anterior spinal reconstruction; lateral access surgery; minimally invasive lateral corpectomy; minimally invasive surgery; osteoporotic vertebral collapse; osteoporotic vertebral fracture; rectangular footplate
Year: 2021 PMID: 34884365 PMCID: PMC8658075 DOI: 10.3390/jcm10235664
Source DB: PubMed Journal: J Clin Med ISSN: 2077-0383 Impact factor: 4.241
Figure 1Flowchart for patient selection.
Figure 2Representative pre- and postoperative radiographs of patients in (a) Group C and (b) Group L.
Figure 3Measurements of the radiographic image. The upper and lower dashed lines indicate the local lordotic angle (LLA).
Demographics.
| Group C, | Group L, | ||
|---|---|---|---|
| Age (years), (SD) | 74.1 (5.7) | 76.2 (6.2) | 0.24 |
| Sex, Male | 11 (50.0%) | 9 (37.5%) | 0.39 |
| Postinjury period | 0.67 | ||
| <1 month | 2 (9.1%) | 4 (17%) | |
| more | 20 (91%) | 20 (83%) | |
| Smoking | 0.11 | ||
| Current | 4 (18%) | 2 (8.3%) | |
| Ex-smoker | 8 (36%) | 4 (17%) | |
| No | 10 (45%) | 18 (75%) | |
| Comorbidities | |||
| Cardiovascular | 3 (13.6%) | 6 (25.0%) | 0.46 |
| Respiratory | 2 (9.1%) | 1 (4.2%) | 0.60 |
| Diabetes mellitus | 7 (31.8%) | 6 (25.0%) | 0.61 |
| Hypertension | 15 (68.2%) | 17 (70.8%) | 0.85 |
| Hyperlipidemia | 3 (13.6%) | 3 (12.5%) | >0.99 |
| Stroke | 2 (9.1%) | 0 (0.0%) | 0.22 |
| Hepatic | 2 (9.1%) | 1 (4.2%) | 0.60 |
| Rheumatoid arthritis | 0 (0.0%) | 1 (4.2%) | >0.99 |
| T-score 1 (SD) | −1.82 (0.77) | −1.76 (1.20) | 0.85 |
| Osteoporosis treatment | 0.16 | ||
| No | 19 (86%) | 23 (96%) | |
| Teriparatide | 2 (9.1%) | 0 (0%) | |
| Oral bisphosphonate | 1 (4.5%) | 0 (0%) | |
| SERM | 0 (0%) | 1 (4.2%) | |
| Lesion level | 0.10 | ||
| T9 | 1 (4.5%) | 0 (0%) | |
| T10 | 0 (0%) | 1 (4.2%) | |
| T11 | 0 (0%) | 1 (4.2%) | |
| T12 | 5 (23%) | 8 (33%) | |
| L1 | 9 (41%) | 8 (33%) | |
| L2 | 5 (23%) | 1 (4.2%) | |
| L3 | 0 (0%) | 4 (17%) | |
| L4 | 2 (9.1%) | 1 (4.2%) | |
| ASIA classification | 0.33 | ||
| C | 5 (23%) | 9 (38%) | |
| D | 5 (23%) | 7 (29%) | |
| E | 12 (55%) | 8 (33%) |
SERM, selective estrogen receptor modulator; ASIA, American Spinal Cord Injury Association. 1: T-score detected by dual-energy X-ray absorptiometry of proximal femur.
Posterior surgery summary.
| Group C, | Group L, | ||
|---|---|---|---|
| Fusion range | 0.44 | ||
| 1 above–1 below | 4 (18%) | 2 (8.3%) | |
| 2 above–1 below | 5 (23%) | 9 (38%) | |
| 2 above–2 below | 10 (45%) | 12 (50%) | |
| more | 3 (14%) | 1 (4.2%) | |
| Augmentation | |||
| Sublaminar wire | 15 (68%) | 17 (71%) | 0.85 |
| Hook | 10 (45%) | 20 (83%) | 0.01 |
| Decompression | 12 (55%) | 4 (17%) | 0.01 |
Anterior surgery and perioperative summary.
| Group C, | Group L, | ||
|---|---|---|---|
| Anterior surgery | |||
| Op time (min), (SD) | 248 (68) | 183 (41) | <0.001 |
| Blood loss (mL), (SD) | 406 (432) | 148 (137) | 0.01 |
| Anterior approach | <0.001 | ||
| Thoracotomy | 5 (23%) | 0 (0%) | |
| Extrapleural | 11 (50%) | 7 (29%) | |
| Transdiaphragm | 0 (0%) | 12 (50%) | |
| Retroperitoneal | 6 (27%) | 5 (21%) | |
| Chest drain 1 | 7 (44%) | 4 (21%) | 0.49 |
| Complications | |||
| Respiratory | 5 (23%) | 1 (4.2%) | 0.09 |
| Stroke | 0 (0%) | 1 (4.2%) | >0.99 |
| Delirium | 4 (18%) | 3 (12%) | 0.69 |
| Thigh symptom | 2 (9.1%) | 2 (8.3%) | 0.90 |
| SSI (superficial) | 1 (4.5%) | 0 (0%) | 0.48 |
| Implant failure | 2 (9.1%) | 0 (0%) | 0.22 |
| Vertebral fracture | 6 (27%) | 5 (21%) | 0.61 |
| Osteoporosis treatment | 0.47 | ||
| No | 11 (50%) | 8 (33%) | |
| Teriparatide | 9 (41%) | 13 (54%) | |
| Oral bisphosphonate | 1 (4.5%) | 1 (4.2%) | |
| Denosumab | 0 (0%) | 2 (8.3%) | |
| SERM | 1 (4.5%) | 0 (0%) |
SSI, surgical site infection; SERM, selective estrogen receptor modulator. 1: Indicates the percentage excluding cases treated with the retroperitoneal approach.
Summary of radiological survey.
| Group C, | Group L, | ||
|---|---|---|---|
| LLA (°), (SD) | |||
| Preoperative | −16.4 (10.8) | −19.5 (18.4) | 0.49 |
| Postoperative | −0.8 (11.6) | 0.2 (12.4) | 0.78 |
| 1 year | −5.7 (14.8) | −1.7 (12.2) | 0.34 |
| 2 year | −7.4 (16.9) | −2.3 (11.9) | 0.27 |
| LLA loss (°), (SD) | |||
| 1 year | 4.9 (5.0) | 1.9 (2.5) | 0.02 |
| 2 years | 6.5 (7.6) | 2.5 (3.0) | 0.04 |
| Loss over 10°, 1 year | 3 (15%) | 1 (4.2%) | 0.32 |
| Loss over 10°, 2 years | 5 (25%) | 1 (4.2%) | 0.08 |
| Cage subsidence | 16 (80%) | 7 (29%) | <0.001 |
| Bony union | |||
| 1 year | 9 (45%) | 14 (58%) | 0.38 |
| 2 years | 13 (65%) | 22 (92%) | 0.06 |
| Trabecula through cage | 12 (60%) | 7 (29%) | 0.04 |
| Paravertebral bridging bone | 6 (30%) | 15 (62%) | 0.03 |
| Approach side | 6 (30%) | 10 (42%) | 0.42 |
| Opposite side | 0 (0%) | 8 (33%) | 0.01 |
| PS loosening | 4 (20%) | 3 (12%) | 0.68 |
1: Two patients who experienced implant failure (cage deviation) were excluded.
Figure 4Time course of local lordotic angle.
Figure 5Paravertebral bridging bone formed on the opposite side of the approach (lateral approach vertebral body reconstruction (LAVR) patient).
Clinical status after 2 years.
| Group C, | Group L, | ||
|---|---|---|---|
| ASIA classification | 0.25 | ||
| D | 2 (9.1%) | 6 (25%) | |
| E | 20 (91%) | 18 (75%) | |
| Ambulation | 0.96 | ||
| Gait alone | 9 (41%) | 10 (42%) | |
| Gait with cane | 9 (41%) | 11 (46%) | |
| Gait with cart | 2 (9.1%) | 2 (8.3%) | |
| Wheelchair | 2 (9.1%) | 1 (4.2%) |
ASIA, American Spinal Cord Injury Association.
Comparison of the conventional procedure and LAVR.
| Conventional Procedure | LAVR | |
|---|---|---|
| Skin incision | ||
| Thoracic/thoracolumbar | ~20 cm | 5 cm |
| Lumbar | ~20 cm | 5 cm |
| Retractor | Conventional retractor | Dedicated retractor |
| Field of vision | Broad | Limited |
| Approach | ||
| Thoracic/thoracolumbar | Thoracotomy | Extrapleural |
| Lumbar | Retroperitoneal | Retroperitoneal |
| Available cage | Cylindrical footplate cage | Rectangular footplate cage |
| Operation time | > | |
| Blood loss | > | |
| 2-year correction loss | > | |
| 2-year bony fusion | < | |
| Learning curve | Steep | |
LAVR, lateral access vertebral reconstruction; XLIF, extreme lateral interbody fusion.